Kingsview Wealth Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$580K Sell
5,291
-1,515
-22% -$216K 0.01% 849
2025
Q4
$1.13M Buy
6,806
+729
+12% +$122K 0.02% 603
2025
Q3
$1.19M Buy
6,077
+827
+16% +$136K 0.02% 567
2025
Q2
$475K Sell
5,250
-2,290
-30% -$181K 0.01% 784
2025
Q1
$450K Buy
7,540
+50
+0.7% +$4.63K 0.01% 763
2024
Q4
$992K Buy
7,490
+1,260
+20% +$118K 0.02% 550
2024
Q3
$326K Sell
6,230
-125
-2% -$5.87K 0.01% 858
2024
Q2
$385K Buy
+6,355
New +$441K 0.01% 760

Other funds holding ALAB

Kingsview Wealth Management's ALAB Position: Q1 2026 in Review

Kingsview Wealth Management reduced its Astera Labs (ALAB) stake by 22% in Q1 2026, selling an estimated $216K and leaving 5,291 shares worth $580K. The position accounts for 0.01% of the portfolio, ranked #849.

Kingsview Wealth Management first reported a position in ALAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.19M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Kingsview Wealth Management held 5,291 shares of Astera Labs worth $580K as of Q1 2026.
  • Kingsview Wealth Management sold 1,515 Astera Labs shares in Q1 2026, an estimated $216K.
  • Astera Labs made up 0.01% of Kingsview Wealth Management's portfolio in Q1 2026, its #849 holding.
  • Kingsview Wealth Management first reported a position in Astera Labs in Q2 2024 and has held it in 8 quarters since.
  • Kingsview Wealth Management's Astera Labs position peaked at $1.19M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.